109 related articles for article (PubMed ID: 10693165)
1. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1999; 35(2):127-9. PubMed ID: 10693165
[TBL] [Abstract][Full Text] [Related]
2. Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 1998; 32(2):76-80. PubMed ID: 9919615
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in advanced gastrointestinal cancer patients with weight loss.
O'Gorman P; McMillan DC; McArdle CS
Nutr Cancer; 2000; 37(1):36-40. PubMed ID: 10965517
[TBL] [Abstract][Full Text] [Related]
4. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer.
Barber MD; Ross JA; Fearon KC
Nutr Cancer; 1999; 35(2):106-10. PubMed ID: 10693162
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients.
McMillan DC; Scott HR; Watson WS; Preston T; Milroy R; McArdle CS
Nutr Cancer; 1998; 31(2):101-5. PubMed ID: 9770720
[TBL] [Abstract][Full Text] [Related]
6. Performance status of male and female advanced cancer patients is independently predicted by mid-upper arm circumference measurement.
McMillan DC; Forrest LM; O'Gorman P; Angerson WJ; McArdle CS
Nutr Cancer; 2002; 42(2):191-3. PubMed ID: 12416259
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.
McMillan DC; Wigmore SJ; Fearon KC; O'Gorman P; Wright CE; McArdle CS
Br J Cancer; 1999 Feb; 79(3-4):495-500. PubMed ID: 10027319
[TBL] [Abstract][Full Text] [Related]
8. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
[TBL] [Abstract][Full Text] [Related]
9. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.
Simons JP; Schols AM; Buurman WA; Wouters EF
Clin Sci (Lond); 1999 Aug; 97(2):215-23. PubMed ID: 10409477
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study.
Bolukbas FF; Kilic H; Bolukbas C; Gumus M; Horoz M; Turhal NS; Kavakli B
BMC Cancer; 2004 Jun; 4():29. PubMed ID: 15217519
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.
Jamieson NB; Brown DJ; Michael Wallace A; McMillan DC
Cytokine; 2004 Jul 21-Aug 7; 27(2-3):90-2. PubMed ID: 15242698
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
[TBL] [Abstract][Full Text] [Related]
13. Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients.
Wallace AM; Kelly A; Sattar N; McArdle CS; McMillan DC
Nutr Cancer; 2002; 44(2):157-60. PubMed ID: 12734062
[TBL] [Abstract][Full Text] [Related]
14. Serum albumin, body weight and inflammatory parameters in chronic hemodialysis patients: a three-year longitudinal study.
Bossola M; La Torre G; Giungi S; Tazza L; Vulpio C; Luciani G
Am J Nephrol; 2008; 28(3):405-12. PubMed ID: 18087147
[TBL] [Abstract][Full Text] [Related]
15. Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy.
Erkurt E; Erkisi M; Tunali C
J Exp Clin Cancer Res; 2000 Dec; 19(4):431-9. PubMed ID: 11277319
[TBL] [Abstract][Full Text] [Related]
16. Effects of nutritional support in patients with colorectal cancer during chemotherapy.
Dintinjana RD; Guina T; Krznarić Z; Radić M; Dintinjana M
Coll Antropol; 2008 Sep; 32(3):737-40. PubMed ID: 18982745
[TBL] [Abstract][Full Text] [Related]
17. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia.
Lundholm K; Daneryd P; Körner U; Hyltander A; Bosaeus I
Int J Oncol; 2004 Mar; 24(3):505-12. PubMed ID: 14767534
[TBL] [Abstract][Full Text] [Related]
18. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status.
Taylor LA; Arends J; Hodina AK; Unger C; Massing U
Lipids Health Dis; 2007 Jul; 6():17. PubMed ID: 17623088
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.
Read JA; Choy ST; Beale PJ; Clarke SJ
Nutr Cancer; 2006; 55(1):78-85. PubMed ID: 16965244
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
